For as long as Josie Heath-Smith can remember, she has suffered from brain fog, fatigue and an inability to concentrate.

When combined, a subjective list of common childhood behaviors (fidgeting, losing things, distractibility, not following ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Attention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...

Half of clinical trials on adult ADHD lack thorough diagnostic assessments, undermining their reliability and treatment ...

Increasing access to ADHD diagnosis and medication is a good move. But it shouldn’t be the whole plan to address a condition ...

The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...

Top Reactions for All Ages: There have been 17,021 Adverse Drug Reactions in connection with ADHD drugs/stimulants that have been reported to the FDA’s Adverse Event Reporting System (MedWatch), ...

Understanding ADHD Treatment & Support in Australia ADHD (Attention Deficit Hyperactivity Disorder) affects individuals ...

U.S health officials are updating the prescribing labels of long-acting ADHD medications to carry new warnings for children ...